Authors
Oualline, G., Noon, M.
Abstract
DNA synthesis machines are vital tools in medicine and research, but they can be misused to produce sequences which are transcribed and translated to produce toxic proteins. Synthesis providers may screen orders for dangerous sequences, but most screening software performs sequence-based alignment, which is vulnerable to AI redesign attacks. Additionally, software-only synthesis screening requires the operator of the machine to be trusted. We present Capiti, an edge-deployed screening system that runs with no internet connection, listens directly to a synthesizer's valve control signals, and aborts a run when it detects incipient pathogenic function. Rather than performing sequence alignment, Capiti is specifically trained to recognize fold. ProteinMPNN was used to generate putatively functional variants of known pathogenic proteins, and a CNN was trained to separate them from active-site knockouts, scrambles, and decoys. We release two models, Capiti-E (known pathogenic proteins) and Capiti-C (resistance genes for antibiotics of last resort), alongside emusynth, a DNA synthesizer emulator. On our test sets, IBBIS commec and SeqScreen incorrectly passed 18.5% and 44.7% of putatively functional pathogenic variants respectively; Capiti passed 0.24%.
Preprint server:
bioRxiv
The authors list and abstract were imported from bioRxiv on 22 Oct 2026.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 20
- Comments 0